Subscribe to our Email Alerts
Menu
Home
About Us
Company Overview
Company Values
Board of Directors
Executive Management
Corporate Directory
Products
DAYBUE® (trofinetide)
Pipeline
Pipeline
NNZ-2591
Phelan-McDermid Syndrome
Angelman Syndrome
Pitt Hopkins Syndrome
Hypoxic-ischemic encephalopathy
Prader-Willi Syndrome
Compassionate Use
Science
Science Behind Neuren's Products
Trofinetide Published Studies & Presentations
Rett Syndrome
NNZ-2591Published Studies & Presentations
Phelan-McDermid Syndrome
Pitt Hopkins Syndrome
Angelman Syndrome
Investors
Investor Dashboard
Share Price Information
ASX Announcements
Annual and Interim Reports
Investor Presentations
Corporate Governance
Analyst Coverage
Shareholder Services
News & Media
Media
Contact
Contact Us
Email Alerts
News & Media
Home
>
News & Media
>
Media
Media
Media
Filter by Year:
2026
2025
2024
14-Jan-2026
Jon Pilcher on Ausbiz: Neuren boosted by favourable sales forecast
29-Nov-2025
Marcus Today On the Couch with Jon Pilcher Neuren Pharma CEO - November 2025
7-Nov-2025
Jon Pilcher on Ausbiz: Neuren eyes global growth as DAYBUE sales impress
22-Oct-2025
Inside NEU: The ASX pharma star with a long runway for growth
20-Oct-2025
Jon Pilcher on Ausbiz
19-Sep-2025
Biotech Showcase 2025 presentation
5-Jun-2025
Neuren Pharmaceuticals: Under the Microscope
19-Mar-2025
belldirect interview
19-Mar-2025
Sharecafe and Finance News Network presentation
20-Jan-2025
43rd J.P. Morgan Healthcare Conference Presentation Webcast
1
2
3
Next
